RecruitingNCT06594913

Eating Disorders Genetics Initiative 2


Sponsor

University of North Carolina, Chapel Hill

Enrollment

20,000 participants

Start Date

Oct 28, 2024

Study Type

OBSERVATIONAL

Conditions

Summary

The overarching intention of the Eating Disorder Genetics Initiative 2 (EDGI2) is to increase sample size, diversity, and eating disorder phenotypes. The investigators are enrolling 20,000 new participants with anorexia nervosa (AN), bulimia nervosa (BN), binge-eating disorder (BED), avoidant/restrictive food intake disorder (ARFID), and controls in the US, Mexico, Australia, New Zealand, Sweden, and Denmark. A primary study goal is to enroll at least 30% of participants from underrepresented groups. Participants are asked to complete a series of questionnaires and submit a saliva sample for genotyping. The goal is to better understand eating disorders and how they relate to each other so that better treatments can be developed.


Eligibility

Min Age: 12 YearsMax Age: 99 Years

Inclusion Criteria2

  • A lifetime history of anorexia nervosa, bulimia nervosa, binge-eating disorder, avoidant restrictive food intake disorders or no history of any disordered eating behavior, based on DSM-5 criteria algorithms
  • Age 12-99 years, depending on country. (US enrollment age is 18-99)

Exclusion Criteria1

  • History of subthreshold disordered eating behaviors.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

OTHEREating disorder diagnosis group

This is an observational study, no active intervention is applied. Participants are assigned to an eating disorder diagnosis group based on their lifetime history of disordered eating behaviors and symptoms.


Locations(5)

University of North Carolina at Chapel Hill

Chapel Hill, North Carolina, United States

QIMR Berghofer

Brisbane, Queensland, Australia

Comenzar de Nuevo

Monterrey, Mexico

University of Otago

Christchurch, Canterbury, New Zealand

Karolinska Institutet

Stockholm, Sweden

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06594913


Related Trials